Canopy Growth(US:CGC) ZACKS·2026-01-16 23:00Company Performance - Canopy Growth Corporation (CGC) closed at $1.19, reflecting a -2.87% change from the previous day, underperforming the S&P 500's daily loss of 0.06% [1] - Over the past month, shares of Canopy Growth have decreased by 27.81%, while the Medical sector has lost 0.79% and the S&P 500 has gained 1.99% [1] Earnings Estimates - The upcoming earnings release for Canopy Growth is projected to show an earnings per share (EPS) of -$0.03, which represents a 96.05% increase from the same quarter last year [2] - Revenue is estimated to be $50.59 million, indicating a 5.34% decline compared to the corresponding quarter of the previous year [2] Full Year Projections - For the full year, the Zacks Consensus Estimates project an EPS of -$0.21 and revenue of $199.68 million, reflecting changes of +92.95% and +3.3% respectively from the prior year [3] - Recent changes to analyst estimates suggest evolving short-term business trends, with positive revisions indicating analyst optimism regarding the company's profitability [3] Zacks Rank and Industry Performance - Canopy Growth currently holds a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate remaining unchanged over the last 30 days [5] - The Medical - Products industry, which includes Canopy Growth, has a Zacks Industry Rank of 162, placing it in the bottom 34% of over 250 industries [6]